Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 37
Filter
Add more filters










Publication year range
1.
Mol Ther Nucleic Acids ; 29: 969-978, 2022 Sep 13.
Article in English | MEDLINE | ID: mdl-36189081

ABSTRACT

Transforming growth factor ß (TGF-ß) is a multifunctional cytokine that plays crucial pathophysiological roles in various diseases, such as cancer and fibrosis. However, the disease modulation by targeting TGF-ß1 isoform remains to be established, regardless of several studies employed with limited antibodies. Here, we developed an RNA aptamer to human active TGF-ß1, named APT-ß1, and characterized its properties in vitro and in vivo. APT-ß1 bound to human and mouse active TGF-ß1 proteins with high affinity and specificity and strongly inhibited TGF-ß1-induced downstream signaling and cell morphology with 50% inhibition concentration (IC50) values at picomolar concentrations. In a xenograft mouse model of non-small cell lung cancer, APT-ß1 alone showed no appreciable effect on tumor growth, while it greatly enhanced the anti-tumor effect of gefitinib, an approved tyrosine kinase inhibitor. These findings strongly suggest that the anti-TGF-ß1 medication may be a promising cancer therapy to suppress repopulation of lung cancer in combination with certain anti-cancer drugs, such as gefitinib.

2.
Surg Case Rep ; 6(1): 288, 2020 Nov 16.
Article in English | MEDLINE | ID: mdl-33196861

ABSTRACT

BACKGROUND: Bowel herniation through a defect in the broad ligament of the uterus is a rare disease and few cases of recurrence have been reported. We report herein a recurrence case of a patient with broad ligament hernia (BLH), along with a review of the literature. CASE PRESENTATION: A 53-year-old woman complaining of abdominal pain was transported to our hospital. She had a history of laparotomy for small-bowel obstruction associated with hernia in the broad ligament of the uterus 10 years ago at a local hospital. Abdominal pelvic contrast-enhanced computed tomography revealed that the mesentery of the dilated bowels converged at a thick band in the pelvis, suggesting closed loop obstruction of the small bowel. The patient underwent urgent laparotomy and was diagnosed with bowel herniation through an opening in the broad ligament of the uterus on the right side, which was ipsilateral with the previous surgery. The hernia orifice was widened by incision and incarcerated bowel segments were released and preserved because ischemia was reversible. The membranous defect of BLH was closed by suture with braded silk strings. CONCLUSIONS: Although BLH is a rare disease, patients face a significant risk of disease recurrence. Nonabsorbable suture may be advisable for closure of the hernia orifice in BLH.

3.
J Gen Virol ; 100(5): 736-737, 2019 05.
Article in English | MEDLINE | ID: mdl-30835197

ABSTRACT

Solinviviridae is a family of picorna/calici-like viruses with non-segmented, linear, positive-sense RNA genomes of approximately 10-11 kb. Unusually, their capsid proteins are encoded towards the 3'-end of the genome where they can be expressed both from a subgenomic RNA and as an extension of the replication (picorna-like helicase-protease-polymerase) polyprotein. Members of two species within the family infect ants, but related unclassified virus sequences derive from a large variety of insects and other arthropods. This is a summary of the International Committee on Taxonomy of Viruses (ICTV) Report on the Solinviviridae, which is available at www.ictv.global/report/solinviviridae.


Subject(s)
RNA Viruses/classification , RNA Viruses/genetics , Animals , Arthropods/virology , Capsid Proteins/genetics , Genome, Viral/genetics , RNA, Viral/genetics , Virus Replication/genetics
4.
J Gen Virol ; 100(4): 554-555, 2019 04.
Article in English | MEDLINE | ID: mdl-30835199

ABSTRACT

Polycipiviridae is a family of picorna-like viruses with non-segmented, linear, positive-sense RNA genomes of approximately 10-12 kb. Unusually for viruses within the order Picornavirales, their genomes are polycistronic, with four (or more) consecutive 5'-proximal open reading frames (ORFs) encoding structural (and possibly other) proteins and a long 3' ORF encoding the replication polyprotein. Members of species within the family have all been detected in ants or via arthropod transcriptomic datasets. This is a summary of the International Committee on Taxonomy of Viruses (ICTV) Report on the Polycipiviridae, which is available at www.ictv.global/report/polycipiviridae.


Subject(s)
RNA Viruses/classification , Animals , Ants/virology , Genome, Viral , Open Reading Frames , Phylogeny , RNA Viruses/genetics , RNA Viruses/isolation & purification , RNA Viruses/ultrastructure , Viral Proteins/genetics , Viral Proteins/metabolism
5.
Ann Coloproctol ; 34(2): 94-100, 2018 Apr.
Article in English | MEDLINE | ID: mdl-29742859

ABSTRACT

PURPOSE: Small bowel obstruction (SBO) remains a common complication after pelvic or abdominal surgery. However, the risk factors for SBO in ulcerative colitis (UC) surgery are not well known. The aim of the present study was to clarify the risk factors associated with SBO after ileal pouch-anal anastomosis (IPAA) with a loop ileostomy for patients with UC. METHODS: The medical records of 96 patients who underwent IPAA for UC between 1999 and 2011 were reviewed. SBO was confirmed based on the presence of clinical symptoms and radiographic findings. The patients were divided into 2 groups: the SBO group and the non-SBO group. We also analyzed the relationship between SBO and computed tomography (CT) scan image parameters. RESULTS: The study included 49 male and 47 female patients. The median age was 35.5 years (range, 14-72 years). We performed a 2- or 3-stage procedure as a total proctocolectomy and IPAA for patients with UC. SBO in the pretakedown of the loop ileostomy after IPAA occurred in 22 patients (22.9%). Moreover, surgical intervention for SBO was required for 11 patients. In brief, closure of the loop ileostomy was performed earlier than expected. A multivariate logistic regression analysis revealed that the 2-stage procedure (odds ratio, 2.850; 95% confidence interval, 1.009-8.044; P = 0.048) was a significant independent risk factor associated with SBO. CT scan image parameters were not significant risk factors of SBO. CONCLUSION: The present study suggests that a 2-stage procedure is a significant risk factor associated with SBO after IPAA in patients with UC.

6.
PLoS One ; 12(4): e0175633, 2017.
Article in English | MEDLINE | ID: mdl-28423032

ABSTRACT

A putative novel rhabdovirus (SfRV) was previously identified in a Spodoptera frugiperda cell line (Sf9 cells [ATCC CRL-1711 lot 58078522]) by next generation sequencing and extensive bioinformatic analysis. We performed an extensive analysis of our Sf9 cell bank (ATCC CRL-1711 lot 5814 [Sf9L5814]) to determine whether this virus was already present in cells obtained from ATCC in 1987. Inverse PCR of DNA isolated from Sf9 L5814 cellular DNA revealed integration of SfRV sequences in the cellular genome. RT-PCR of total RNA showed a deletion of 320 nucleotides in the SfRV RNA that includes the transcriptional motifs for genes X and L. Concentrated cell culture supernatant was analyzed by sucrose density gradient centrifugation and revealed a single band at a density of 1.14 g/ml. This fraction was further analysed by electron microscopy and showed amorphous and particulate debris that did not resemble a rhabdovirus in morphology or size. SDS-PAGE analysis confirmed that the protein composition did not contain the typical five rhabdovirus structural proteins and LC-MS/MS analysis revealed primarily of exosomal marker proteins, the SfRV N protein, and truncated forms of SfRV N, P, and G proteins. The SfRV L gene fragment RNA sequence was recovered from the supernatant after ultracentrifugation of the 1.14 g/ml fraction treated with diethyl ether suggesting that the SfRV L gene fragment sequence is not associated with a diethyl ether resistant nucleocapsid. Interestingly, the 1.14 g/ml fraction was able to transfer baculovirus DNA into Sf9L5814 cells, consistent with the presence of functional exosomes. Our results demonstrate the absence of viral particles in ATCC CRL-1711 lot 5814 Sf9 cells in contrast to a previous study that suggested the presence of infectious rhabdoviral particles in Sf9 cells from a different lot. This study highlights how cell lines with different lineages may present different virosomes and therefore no general conclusions can be drawn across Sf9 cells from different laboratories.


Subject(s)
Genome, Viral , RNA, Viral/genetics , Rhabdoviridae/genetics , Sf9 Cells/virology , Virosomes/genetics , Animals , Baculoviridae/genetics , Baculoviridae/ultrastructure , Centrifugation, Density Gradient , DNA/genetics , DNA/isolation & purification , Electrophoresis, Polyacrylamide Gel , High-Throughput Nucleotide Sequencing , RNA, Viral/isolation & purification , Rhabdoviridae/ultrastructure , Spodoptera , Virion/genetics , Virion/ultrastructure , Virosomes/isolation & purification , Virosomes/ultrastructure
7.
Biochem Biophys Res Commun ; 484(1): 1-7, 2017 02 26.
Article in English | MEDLINE | ID: mdl-28115162

ABSTRACT

When translating mRNAs are cleaved in protein-coding regions, 5' fragments of mRNAs are detached from stop codons (i.e., nonstop mRNAs) and protected from 3'-5' exonucleases by ribosomes stalled at the 3' termini. It has been shown in yeast that the nonstop mRNA decay (NSD) machinery triggers nonstop mRNA degradation by removing stalled ribosomes in the artificial reporter mRNAs. However, it is not known well whether NSD is involved in the degradation of endogenous nonstop mRNAs in higher eukaryotes. In this work, we addressed the question of whether 5'-nonstop-mRNA fragments generated by siRNA cleavage or nonsense-mediated-mRNA decay (NMD) are degraded by the NSD pathway in Drosophila melanogaster cells by knocking down three NSD components, Pelota (a yeast Dom34 homolog), Hbs1 and ABCE1 (a ribosome-recycling factor). We found that double, but not single, knockdown of any two of these three factors efficiently stabilized nonstop reporter mRNAs and triple knockdown of Pelota, Hbs1 and ABCE1 further stabilized nonstop mRNAs in highly ribosome-associated state. These findings demonstrated that Pelota, Hbs1 and ABCE1 are crucial for NSD in Drosophila cells as in yeast for rescuing stalled ribosomes and degrading nonstop mRNAs. To our knowledge, this is the first comprehensive report to show the involvement of the NSD machinery in the clearance of mRNA 5'-fragments produced by RNAi and NMD in eukaryotes.


Subject(s)
RNA Interference , RNA, Messenger/metabolism , Animals , Drosophila Proteins/genetics , Drosophila Proteins/metabolism , Drosophila melanogaster
8.
Gan To Kagaku Ryoho ; 43(12): 2166-2168, 2016 Nov.
Article in Japanese | MEDLINE | ID: mdl-28133257

ABSTRACT

A46 -year-old male presented with bloody stool and a descending colon tumor, as identified using colon fiberscopy. The patient did not complain of any remarkable abdominal symptoms. Computed tomography revealed descending colon tumor intussusception. We performed partial resection of the descending colon and D2 lymphadenectomy without intraoperative reduction. The descending colon was barely attached to the retroperitoneum and was mobile. The underlying tumor was type 1 and measured 8.3×5.8 cm. The pathology report indicated a mucinous adenocarcinoma with extension through the submucosa into the subserosa, and metastasis in 6 nearby lymph nodes(n2). Intussusception is relatively rare in adults, particularly in portions of the colon fixed to the retroperitoneum, such as the descending colon. In contrast to previous reports of descending colon intussusception caused by age-related tissue dysfunction, we report our experience with a young patient and present the results obtained.


Subject(s)
Adenocarcinoma, Mucinous/surgery , Colon, Descending/surgery , Colonic Diseases/surgery , Colonic Neoplasms/surgery , Intussusception/surgery , Adenocarcinoma, Mucinous/complications , Adenocarcinoma, Mucinous/drug therapy , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Capecitabine , Colon, Descending/pathology , Colonic Diseases/etiology , Colonic Neoplasms/complications , Colonic Neoplasms/drug therapy , Colonic Neoplasms/pathology , Deoxycytidine/analogs & derivatives , Deoxycytidine/therapeutic use , Fluorouracil/analogs & derivatives , Fluorouracil/therapeutic use , Humans , Intussusception/etiology , Male , Middle Aged , Oxaloacetates
9.
FEBS Lett ; 589(17): 2241-7, 2015 Aug 04.
Article in English | MEDLINE | ID: mdl-26172506

ABSTRACT

The involvement of polypeptide chain-releasing factor eRF3 in translation termination and mRNA decay is well established. Moreover, the finding that the proteolytically processed isoform of eRF3 (p-eRF3) interacts with inhibitors of apoptosis proteins (IAPs) to activate caspase, implies that eRF3 is a cell death regulator. However, the protease(s) responsible for p-eRF3 production and how p-eRF3 regulates apoptosis remain unknown. Here, we show that calpain mediates p-eRF3 production in vitro and in living cells. p-eRF3 is produced in cells treated with ER stressors in a calpain-dependent manner. These findings suggest that p-eRF3 is a novel regulator of calpain-dependent cell death.


Subject(s)
Calcium/metabolism , Calpain/metabolism , Peptide Termination Factors/metabolism , X-Linked Inhibitor of Apoptosis Protein/metabolism , Blotting, Western , Cell Line, Tumor , Endoplasmic Reticulum Stress , HEK293 Cells , Humans , Peptide Termination Factors/genetics , Protein Binding , Protein Isoforms/metabolism , Proteolysis
10.
Gan To Kagaku Ryoho ; 42(12): 1559-60, 2015 Nov.
Article in Japanese | MEDLINE | ID: mdl-26805095

ABSTRACT

OBJECTIVES: The aim of this study was to evaluate the usefulness of gastrojejunal bypass surgery performed in patients presenting with upper gastrointestinal tract obstruction due to unresectable advanced cancer. SUBJECTS AND METHODS: The subjects were 21 patients who underwent gastrojejunal bypass surgery at our division between 2010 and 2014 for symptom palliation. We retrospectively evaluated the operative outcomes, whether chemotherapy was administered, the oral ingestion period, and survival time. RESULTS: The median postoperative day of starting oral ingestion was 6 (range: 2-42), and the median period from decreased oral ingestion to death was 4 (range: 0-26) days. Twelve patients (57%) were discharged. Postoperative chemotherapy was prescribed to all the 9 patients who desired treatment. The median duration of oral digestion time was 61 days, and the median overall survival time was 92 days. CONCLUSION: Gastrojejunal bypass surgery is found to have the potential to not only make relatively long-term oral ingestion possible, but also broaden available treatment options, such as home care or chemotherapy, thereby contributing to improved quality of life.


Subject(s)
Gastric Outlet Obstruction/surgery , Palliative Care , Pancreatic Neoplasms/complications , Stomach Neoplasms/complications , Aged , Aged, 80 and over , Female , Gastric Bypass , Gastric Outlet Obstruction/etiology , Humans , Male , Middle Aged , Pancreatic Neoplasms/surgery , Quality of Life , Stomach Neoplasms/surgery , Treatment Outcome
11.
BMC Biotechnol ; 14: 111, 2014 Dec 24.
Article in English | MEDLINE | ID: mdl-25540031

ABSTRACT

BACKGROUND: Recombinant hemagglutinin (rHA) is the active component in Flublok®; a trivalent influenza vaccine produced using the baculovirus expression vector system (BEVS). HA is a membrane bound homotrimer in the influenza virus envelope, and the purified rHA protein assembles into higher order rosette structures in the final formulation of the vaccine. During purification and storage of the rHA, disulfide mediated cross-linking of the trimers within the rosette occurs and results in reduced potency. Potency is measured by the Single Radial Immuno-diffusion (SRID) assay to determine the amount of HA that has the correct antigenic form. RESULTS: The five cysteine residues in the transmembrane (TM) and cytoplasmic (CT) domains of the rHA protein from the H3 A/Perth/16/2009 human influenza strain have been substituted to alanine and/or serine residues to produce three different site directed variants (SDVs). These SDVs have been evaluated to determine the impact of the TM and CT cysteines on potency, cross-linking, and the biochemical and biophysical properties of the rHA. Modification of these cysteine residues prevents disulfide bond cross-linking in the TM and CT, and the resulting rHA maintains potency for at least 12 months at 25 °C. The strategy of substituting TM and CT cysteines to prevent potency loss has been successfully applied to another H3 rHA protein (from the A/Texas/50/2012 influenza strain) further demonstrating the utility of the approach. CONCLUSION: rHA potency can be maintained by preventing non-specific disulfide bonding and cross-linked multimer formation. Substitution of carboxy terminal cysteines is an alternative to using reducing agents, and permits room temperature storage of the vaccine.


Subject(s)
Cysteine/chemistry , Hemagglutinin Glycoproteins, Influenza Virus/chemistry , Hemagglutinin Glycoproteins, Influenza Virus/immunology , Influenza A virus/immunology , Influenza Vaccines/chemistry , Influenza Vaccines/immunology , Influenza, Human/virology , Animals , Cysteine/genetics , Cysteine/immunology , Hemagglutinin Glycoproteins, Influenza Virus/genetics , Humans , Influenza A virus/chemistry , Influenza A virus/genetics , Influenza Vaccines/genetics , Influenza, Human/immunology , Influenza, Human/prevention & control , Mice , Mice, Inbred BALB C , Protein Structure, Tertiary , Recombinant Proteins/chemistry , Recombinant Proteins/genetics , Recombinant Proteins/immunology
12.
Biochimie ; 106: 10-6, 2014 Nov.
Article in English | MEDLINE | ID: mdl-25128630

ABSTRACT

When ribosomes encounter mRNAs lacking stop codons, two quality-control machineries, NSD for nonstop mRNA decay and ribosome quality control (RQC) for co-translational degradation of the nonstop protein by the proteasome, are triggered to eliminate aberrant molecules. In yeast, it is known that Dom34 (a homolog of eRF1) and Ltn1 (an E3 ubiquitin ligase) play crucial roles in NSD and RQC, respectively, by triggering ribosome rescue at the 3' end of nonstop mRNAs and proteasome-dependent polypeptide degradation. Here we confirmed the essential role of Ltn1 in RQC for nonstop products in Drosophila cells, and further uncovered a functional role of ABCE1, a eukaryotic ribosome recycling factor, in NSD in Drosophila cells.


Subject(s)
ATP-Binding Cassette Transporters/genetics , Codon, Terminator/genetics , Drosophila Proteins/genetics , Drosophila melanogaster/genetics , RNA Stability/genetics , ATP-Binding Cassette Transporters/metabolism , Animals , Animals, Genetically Modified , Blotting, Northern , Blotting, Western , Cell Line , Drosophila Proteins/metabolism , Drosophila melanogaster/cytology , Drosophila melanogaster/metabolism , Gene Expression , RNA/genetics , RNA/metabolism , RNA Interference , RNA, Messenger/genetics , RNA, Messenger/metabolism , Reverse Transcriptase Polymerase Chain Reaction , Ribosomes/metabolism , Ubiquitin-Protein Ligases/genetics , Ubiquitin-Protein Ligases/metabolism
13.
Biochem Biophys Res Commun ; 445(3): 639-44, 2014 Mar 14.
Article in English | MEDLINE | ID: mdl-24569073

ABSTRACT

The eukaryotic releasing factor eRF3 is a multifunctional protein that plays pivotal roles in translation termination as well as the initiation of mRNA decay. eRF3 also functions in the regulation of apoptosis; eRF3 is cleaved at Ala73 by an as yet unidentified protease into processed isoform of eRF3 (p-eRF3), which interacts with the inhibitors of apoptosis proteins (IAPs). The binding of p-eRF3 with IAPs leads to the release of active caspases from IAPs, which promotes apoptosis. Although full-length eRF3 is localized exclusively in the cytoplasm, p-eRF3 localizes in the nucleus as well as the cytoplasm. We here focused on the role of p-eRF3 in the nucleus. We identified leptomycin-sensitive nuclear export signal (NES) at amino acid residues 61-71 immediately upstream of the cleavage site Ala73. Thus, the proteolytic cleavage of eRF3 into p-eRF3 leads to release an amino-terminal fragment containing NES to allow the relocalization of eRF3 into the nucleus. Consistent with this, p-eRF3 more strongly interacted with the nuclear ARF tumor suppressor than full-length eRF3. These results suggest that while p-eRF3 interacts with IAPs to promote apoptosis in the cytoplasm, p-eRF3 also has some roles in regulating cell death in the nucleus.


Subject(s)
Cell Nucleus/metabolism , Peptide Termination Factors/analysis , Peptide Termination Factors/metabolism , Tumor Suppressor Protein p14ARF/metabolism , Active Transport, Cell Nucleus , Amino Acid Sequence , Apoptosis , Cell Nucleus/ultrastructure , HeLa Cells , Humans , Karyopherins/metabolism , Molecular Sequence Data , Nuclear Export Signals , Open Reading Frames , Peptide Chain Termination, Translational , Protein Interaction Maps , Protein Isoforms/analysis , Protein Isoforms/metabolism , Receptors, Cytoplasmic and Nuclear/metabolism , Tumor Suppressor Protein p14ARF/analysis , Exportin 1 Protein
14.
Gan To Kagaku Ryoho ; 41(12): 1785-7, 2014 Nov.
Article in Japanese | MEDLINE | ID: mdl-25731329

ABSTRACT

A 57-year-old woman was referred to our hospital because of descending colon cancer with multiple liver metastases. Abdominal magneticresonanc e imaging (MRI) revealed 13 liver metastases across the lobes. We started combination che- motherapy with capecitabine/oxaliplatin (CapeOX) and bevacizumab. After 9 courses of the treatment, the number and size of the liver metastases were remarkably reduced on MRI. Left colectomy and partial hepatectomy were performed. Histopathological examination revealed no residual cancer cells in the colon but revealed a few cancer cells in 4 of 7 resected liver specimens. At 11 postoperative months, 1 liver metastasis reappeared, for which we performed laparoscopy-assisted partial hepatectomy. At 21 months after the second operation, the patient was well without any signs of recurrence. Thus, the combination chemotherapy with CapeOX and bevacizumab allowed for the successful resection of the tumor and metastasis in our patient who initially had unresectable colon cancer and multiple liver metastases.


Subject(s)
Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Colon, Descending/pathology , Colonic Neoplasms/drug therapy , Liver Neoplasms/drug therapy , Antibodies, Monoclonal, Humanized/administration & dosage , Bevacizumab , Capecitabine , Colon, Descending/surgery , Colonic Neoplasms/pathology , Colonic Neoplasms/surgery , Deoxycytidine/administration & dosage , Deoxycytidine/analogs & derivatives , Female , Fluorouracil/administration & dosage , Fluorouracil/analogs & derivatives , Humans , Liver Neoplasms/secondary , Liver Neoplasms/surgery , Middle Aged , Organoplatinum Compounds/administration & dosage , Oxaliplatin
15.
Gan To Kagaku Ryoho ; 41(12): 2442-3, 2014 Nov.
Article in Japanese | MEDLINE | ID: mdl-25731551

ABSTRACT

An 81-year-old man presented with chief complaints of abdominal pain and vomiting. Intestinal obstruction was found at the time of admission to a local hospital in October 2011. Conservative treatment provided symptomatic relief; however, he was readmitted with similar symptoms in December 2011. Small-intestinal wall thickening was detected by abdominal and pelvic computed tomography, and he was referred to our hospital. Small-bowel endoscopy revealed an elevated subcircumferential tumor in the jejunum. Biopsy revealed well to moderately differentiated adenocarcinoma diagnosed as jejunal cancer, which caused narrowing of the jejunum. Single-incision laparoscopy-assisted small-bowel resection was performed. The intraoperative findings were a tumor with inflammatory changes in the jejunum and enlarged surrounding lymph nodes. We performed regional lymph node dissection. Histopathological analysis showed moderately differentiated small-intestinal tubular adenocarcinoma and 2 of 5 lymph nodes positive for metastatic cancer cells. After an uneventful postoperative course, he was discharged on day 7. He preferred not to undergo postoperative adjuvant chemotherapy and quickly recovered his activities of daily living postoperatively. He stayed home until he developed abdominal distention resulting from peritoneal recurrence 1 year and 6 months postoperatively and died 1 month later.


Subject(s)
Adenocarcinoma/surgery , Jejunal Neoplasms/surgery , Adenocarcinoma/complications , Aged, 80 and over , Fatal Outcome , Humans , Intestinal Obstruction/etiology , Intestinal Obstruction/surgery , Jejunal Neoplasms/complications , Jejunal Neoplasms/pathology , Laparoscopy , Male , Recurrence
16.
Gan To Kagaku Ryoho ; 40(5): 671-3, 2013 May.
Article in Japanese | MEDLINE | ID: mdl-23863598

ABSTRACT

We report a case of hyperammonemic encephalopathy related to 5-FU in an aged patient with recurrent colon cancer treated with FOLFIRI therapy. An 80-year-old man underwent right hemicolectomy for cecal cancer. After 10 months, surgical resection was performed for its local recurrence. He was then treated with FOLFIRI therapy, and during the fifth course, he presented with a sudden onset of congestive disturbances. Through radiographic examination and laboratory data, only hyperammonemia was found; he was therefore diagnosed with hyperammonemic encephalopathy. By starting branchedamino acid solutions for its treatment, his consciousness and serum ammonia were promptly improved. Hyperammonemic encephalopathy related 5-FU is caused by increasing ammonia production and its metabolic inhibition, and is worsened by renal dysfunction, dehydration, constipation, infections, or body weight loss. On account of the potential decrease of metabolic function of liver and kidney, an aged person tends to have hyperammonnemia more than a youth. Clinicians should be aware of the adverse events associated with hyperammonemia when then administer a large amount of 5-FU to elderly patients.


Subject(s)
Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Appendiceal Neoplasms/drug therapy , Brain Diseases, Metabolic/etiology , Fluorouracil/adverse effects , Hyperammonemia/chemically induced , Aged, 80 and over , Antineoplastic Combined Chemotherapy Protocols/administration & dosage , Appendiceal Neoplasms/pathology , Appendiceal Neoplasms/surgery , Camptothecin/administration & dosage , Camptothecin/analogs & derivatives , Combined Modality Therapy , Fluorouracil/administration & dosage , Humans , Hyperammonemia/drug therapy , Leucovorin/administration & dosage , Male , Recurrence
17.
J Virol ; 87(11): 6391-405, 2013 Jun.
Article in English | MEDLINE | ID: mdl-23536684

ABSTRACT

Baculoviruses are important insect pathogens that have been developed as protein expression vectors in insect cells and as transduction vectors for mammalian cells. They have large double-stranded DNA genomes containing approximately 156 tightly spaced genes, and they present significant challenges for transcriptome analysis. In this study, we report the first comprehensive analysis of AcMNPV transcription over the course of infection in Trichoplusia ni cells, by a combination of strand-specific RNA sequencing (RNA-Seq) and deep sequencing of 5' capped transcription start sites and 3' polyadenylation sites. We identified four clusters of genes associated with distinctive patterns of mRNA accumulation through the AcMNPV infection cycle. A total of 218 transcription start sites (TSS) and 120 polyadenylation sites (PAS) were mapped. Only 29 TSS were associated with a canonical TATA box, and 14 initiated within or near the previously identified CAGT initiator motif. The majority of viral transcripts (126) initiated within the baculovirus late promoter motif (TAAG), and late transcripts initiated precisely at the second position of the motif. Analysis of 3' ends showed that 92 (77%) of the 3' PAS were located within 30 nucleotides (nt) downstream of a consensus termination signal (AAUAAA or AUUAAA). A conserved U-rich region was found approximately 2 to 10 nt downstream of the PAS for 58 transcripts. Twelve splicing events and an unexpectedly large number of antisense RNAs were identified, revealing new details of possible regulatory mechanisms controlling AcMNPV gene expression. Combined, these data provide an emerging global picture of the organization and regulation of AcMNPV transcription through the infection cycle.


Subject(s)
Moths/virology , Nucleopolyhedroviruses/genetics , Transcriptome , Viral Proteins/genetics , Animals , Gene Expression Regulation, Viral , Nucleopolyhedroviruses/metabolism , Open Reading Frames , Regulatory Sequences, Nucleic Acid , Transcription, Genetic , Viral Proteins/metabolism
18.
Apoptosis ; 17(12): 1287-99, 2012 Dec.
Article in English | MEDLINE | ID: mdl-23054082

ABSTRACT

Polypeptide chain release factor eRF3 plays pivotal roles in translation termination and post-termination events including ribosome recycling and mRNA decay. It is not clear, however, if eRF3 is targeted for the regulation of gene expression. Here we show that DNA-damaging agents (UV and etoposide) induce the immediate cleavage and degradation of eRF3 in a caspase-dependent manner. The effect is selective since the binding partners of eRF3, eRF1 and PABP, and an unrelated control, GAPDH, were not affected. Point mutations of aspartate residues within overlapping DXXD motifs near the amino terminus of eRF3 prevented the appearance of the UV-induced cleavage product, identifying D32 as the major cleavage site. The cleavage and degradation occurred in a similar time-dependent manner to those of eIF4G, a previously established caspase-3 target involved in the inhibition of translation during apoptosis. siRNA-mediated knockdown of eRF3 led to inhibition of cellular protein synthesis, supporting the idea that the decrease in the amount of eRF3 caused by the caspase-mediated degradation contributes to the inhibition of translation during apoptosis. This is the first report showing that eRF3 could serve as a target in the regulation of gene expression.


Subject(s)
Apoptosis , Caspase 3/metabolism , DNA Damage/radiation effects , Peptide Termination Factors/metabolism , Apoptosis/radiation effects , Caspase 3/genetics , Cell Line , Gene Expression Regulation , Humans , Peptide Chain Termination, Translational , Peptide Termination Factors/genetics , Proteolysis/radiation effects , Ultraviolet Rays
19.
J Invertebr Pathol ; 107 Suppl: S113-7, 2011 Jul.
Article in English | MEDLINE | ID: mdl-21784226

ABSTRACT

This letter to the editor brings to the attention of researchers an initiative to develop a baculovirus reference material repository. To be successful this initiative needs the support of a broad panel of researchers working with baculovirus vectors for recombinant protein production and gene delivery for either therapy or vaccination. First there is a need to reach a consensus on the nature of the reference material, the production protocols and the baculovirus characterization methods. It will also be important to define repository and distribution procedures so that the reference material is available to any researcher for calibrating experimental data and to compare experiments performed in the various laboratories. As more and more baculovirus-based products are licensed or in the final stages of development, the development of a repository of baculovirus reference material is timely. This letter describes the requirements for the reference material and for the project as a whole to be successful and calls for a partnership that would involve academic, industrial laboratories and governmental organizations to support this international initiative.


Subject(s)
Baculoviridae/genetics , Biological Products/standards , Genetic Engineering/standards , Genetic Vectors/standards , Technology, Pharmaceutical/standards , Gene Expression Regulation, Viral , Genetic Engineering/methods , Genetic Therapy/standards , Humans , Quality Control , Reference Standards , Vaccines, Synthetic/standards
20.
J Invertebr Pathol ; 107 Suppl: S31-41, 2011 Jul.
Article in English | MEDLINE | ID: mdl-21784229

ABSTRACT

The viral surface protein hemagglutinin (HA) has been recognized as a key antigen in the host response to influenza virus in both natural infection and vaccination because neutralizing antibodies directed against HA can mitigate or prevent infection. The baculovirus-insect cell system can be used for the production of recombinant HA molecules and is suitable for influenza vaccine production where annual adjustment of the vaccine is required. This expression system is generally considered safe with minimal potential for growth of human pathogens. Extensive characterization of this novel cell substrate has been performed, none of which has revealed the presence of adventitious agents. Multiple clinical studies have demonstrated that the vaccine is safe, well-tolerated and immunogenic. The baculovirus-insect cell system could, therefore, be used for the expedited production of a safe and efficacious influenza vaccine. As a result, this technology should provide a fast track worldwide solution for newly emerging influenza strains or pandemic preparedness within a few years.


Subject(s)
Baculoviridae/immunology , Influenza Vaccines/immunology , Orthomyxoviridae/immunology , Animals , Baculoviridae/genetics , Gene Expression Regulation, Viral , Hemagglutinins/immunology , Humans , Influenza Vaccines/pharmacology , Influenza, Human/prevention & control , Insecta/virology , Orthomyxoviridae/genetics , Pandemics/prevention & control , Recombinant Proteins , Time Factors , Vaccines, Inactivated/administration & dosage , Vaccines, Inactivated/immunology , Vaccines, Synthetic/administration & dosage , Vaccines, Synthetic/immunology
SELECTION OF CITATIONS
SEARCH DETAIL
...